☰

James C. Garbutt - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacological treatment of alcoholism
Tree Info Grants Similar researchers PubMed Report error

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kampov-Polevoy A, Bobashev G, Garbutt JC. Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 34272558 DOI: 10.1093/alcalc/agab049  0.436
2021 Kampov-Polevoy A, Bobashev G, Garbutt JC. Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 34272558 DOI: 10.1093/alcalc/agab049  0.436
2019 Lerma-Cabrera JM, Carvajal F, Garbutt JC, Navarro M, Thiele TE. The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data. Brain Research. 146628. PMID 31891691 DOI: 10.1016/J.Brainres.2019.146628  0.41
2019 Proeschold-Bell RJ, Evon DM, Yao J, Niedzwiecki D, Makarushka C, Keefe KA, Patkar AA, Mannelli P, Garbutt JC, Wong JB, Wilder JM, Datta SK, Hodge T, Naggie S, Fried MW, et al. A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology (Baltimore, Md.). PMID 31803945 DOI: 10.1002/Hep.31058  0.572
2019 Garbutt JC. Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 31761948 DOI: 10.1093/Alcalc/Agz084  0.492
2019 Walter TJ, Navarro M, Thiele TE, Pedersen C, Kampov-Polevoy A, Garbutt JC. A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 31746964 DOI: 10.1093/Alcalc/Agz076  0.392
2019 Navarro M, Luhn KL, Kampov-Polevoy AB, Garbutt JC, Thiele TE. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice. Alcoholism, Clinical and Experimental Research. PMID 30817015 DOI: 10.1111/Acer.13992  0.423
2018 de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, et al. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective. Frontiers in Psychiatry. 9: 708. PMID 30662411 DOI: 10.3389/Fpsyt.2018.00708  0.404
2018 Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtman M, Jaury P, Lingford-Hughes AR, Morley KC, et al. Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. The Lancet. Psychiatry. PMID 30413394 DOI: 10.1016/S2215-0366(18)30303-1  0.537
2018 Garbutt JC. Use of Baclofen for Alcohol Use Disorders in the United States. Frontiers in Psychiatry. 9: 448. PMID 30298027 DOI: 10.3389/Fpsyt.2018.00448  0.477
2018 Stephens JR, Moore C, Stepanek KV, Garbutt JC, Starke B, Liles A, Jonas DE. Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal. Journal of Hospital Medicine. E1-E8. PMID 29364992 DOI: 10.12788/Jhm.2900  0.498
2017 Jonas DE, Garbutt JC. Screening and Counseling for Unhealthy Alcohol Use in Primary Care Settings. The Medical Clinics of North America. 101: 823-837. PMID 28577629 DOI: 10.1016/J.Mcna.2017.03.011  0.498
2016 Garbutt JC, Kampov-Polevoy AB, Kalka-Juhl LS, Gallop RJ. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial. Jama Psychiatry. PMID 27627782 DOI: 10.1001/Jamapsychiatry.2016.2157  0.602
2016 Berger L, Brondino M, Fisher M, Gwyther R, Garbutt JC. Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal. Journal of the American Board of Family Medicine : Jabfm. 29: 37-49. PMID 26769876 DOI: 10.3122/Jabfm.2016.01.150143  0.575
2014 Jonas DE, Amick HR, Feltner C, Wines R, Shanahan E, Rowe CJ, Garbutt JC. Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis. Pharmacogenomics. 15: 1687-700. PMID 25410894 DOI: 10.2217/Pgs.14.121  0.391
2014 Jonas DE, Feltner C, Garbutt JC. Medications for alcohol use disorders--reply. Jama. 312: 1351. PMID 25268447 DOI: 10.1001/Jama.2014.10170  0.494
2014 Kampov-Polevoy A, Lange L, Bobashev G, Eggleston B, Root T, Garbutt JC. Sweet-liking is associated with transformation of heavy drinking into alcohol-related problems in young adults with high novelty seeking. Alcoholism, Clinical and Experimental Research. 38: 2119-26. PMID 24962796 DOI: 10.1111/Acer.12458  0.561
2014 Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. Jama. 311: 1889-900. PMID 24825644 DOI: 10.1001/jama.2014.3628  0.394
2014 Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction (Abingdon, England). 109: 1274-84. PMID 24661324 DOI: 10.1111/Add.12557  0.509
2013 Nguyen RH, Gillen C, Garbutt JC, Kampov-Polevoi A, Holden JK, Francisco EM, Tommerdahl M. Centrally-mediated sensory information processing is impacted with increased alcohol consumption in college-aged individuals. Brain Research. 1492: 53-62. PMID 23178333 DOI: 10.1016/J.Brainres.2012.11.021  0.563
2013 Berger L, Fisher M, Brondino M, Bohn M, Gwyther R, Longo L, Beier N, Ford A, Greco J, Garbutt JC. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study. Alcoholism, Clinical and Experimental Research. 37: 668-74. PMID 23134193 DOI: 10.1111/Acer.12010  0.521
2013 Pedersen CA, Smedley KL, Leserman J, Jarskog LF, Rau SW, Kampov-Polevoi A, Casey RL, Fender T, Garbutt JC. Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcoholism, Clinical and Experimental Research. 37: 484-9. PMID 23025690 DOI: 10.1111/J.1530-0277.2012.01958.X  0.587
2012 Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, Viera AJ, Wilkins TM, Schwartz CJ, Richmond EM, Yeatts J, Evans TS, Wood SD, Harris RP. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 157: 645-54. PMID 23007881 DOI: 10.7326/0003-4819-157-9-201211060-00544  0.423
2010 Lange LA, Kampov-Polevoy AB, Garbutt JC. Sweet liking and high novelty seeking: independent phenotypes associated with alcohol-related problems. Alcohol and Alcoholism (Oxford, Oxfordshire). 45: 431-6. PMID 20663854 DOI: 10.1093/Alcalc/Agq040  0.545
2010 Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcoholism, Clinical and Experimental Research. 34: 1849-57. PMID 20662805 DOI: 10.1111/J.1530-0277.2010.01273.X  0.455
2010 Garbutt JC. Efficacy and tolerability of naltrexone in the management of alcohol dependence. Current Pharmaceutical Design. 16: 2091-7. PMID 20482515 DOI: 10.2174/138161210791516459  0.52
2010 Dichter GS, Smoski MJ, Kampov-Polevoy AB, Gallop R, Garbutt JC. Unipolar depression does not moderate responses to the Sweet Taste Test. Depression and Anxiety. 27: 859-63. PMID 20336799 DOI: 10.1002/Da.20690  0.328
2010 Leggio L, Garbutt JC, Addolorato G. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. Cns & Neurological Disorders Drug Targets. 9: 33-44. PMID 20201813 DOI: 10.2174/187152710790966614  0.6
2009 Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB. Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol and Alcoholism (Oxford, Oxfordshire). 44: 293-300. PMID 19189996 DOI: 10.1093/Alcalc/Agn122  0.749
2009 Garbutt JC. The state of pharmacotherapy for the treatment of alcohol dependence. Journal of Substance Abuse Treatment. 36: S15-23; quiz S24-5. PMID 19062347  0.527
2008 Garbutt JC. Alcoholism The Medical Basis of Psychiatry: Third Edition. 227-249. DOI: 10.1007/978-1-59745-252-6_14  0.511
2007 Garbutt JC, Flannery B. Baclofen for alcoholism. Lancet. 370: 1884-5. PMID 18068496 DOI: 10.1016/S0140-6736(07)61789-9  0.513
2007 O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. Journal of Clinical Psychopharmacology. 27: 507-12. PMID 17873686 DOI: 10.1097/Jcp.0B013E31814Ce50D  0.554
2007 Gastfriend DR, Garbutt JC, Pettinati HM, Forman RF. Reduction in heavy drinking as a treatment outcome in alcohol dependence. Journal of Substance Abuse Treatment. 33: 71-80. PMID 17588491 DOI: 10.1016/J.Jsat.2006.09.008  0.563
2007 Bradford BU, Karnitsching J, Powell LL, Garbutt JC. Rates of ethanol metabolism decrease in sons of alcoholics following a priming dose of ethanol. Alcohol (Fayetteville, N.Y.). 41: 263-70. PMID 17521843 DOI: 10.1016/J.Alcohol.2007.04.002  0.415
2006 Garbutt JC. Medications for the treatment of alcohol dependence. American Family Physician. 74: 1836. PMID 17168336  0.438
2006 Garbutt JC. New therapeutic options for alcohol dependence: Long-acting intramuscular formulations of naltrexone Journal of Clinical Psychiatry. 67: 30-34.  0.449
2006 Garbutt JC. Emerging pharmacologic treatments for alcohol dependence Journal of Clinical Psychiatry. 67: 35-40.  0.496
2005 Ameisen O, Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Silverman BL, Loewy JW, Ehrich EW, Pettinati HM. Naltrexone treatment for alcohol dependency [3] (multiple letters) Journal of the American Medical Association. 294: 899-900. PMID 16118379  0.502
2005 Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. Jama. 293: 1617-25. PMID 15811981 DOI: 10.1001/Jama.293.13.1617  0.523
2005 Garbutt JC, Kranzler HR, O’Malley SS, Gastfriend DR, Silverman BL, Loewy JW, Ehrich EW, Pettinati HM. Naltrexone Treatment for Alcohol Dependency—Reply Jama. 294: 899-900. DOI: 10.1001/Jama.294.8.900  0.58
2004 Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, Crosby K, Morreale M, Trivette A. Baclofen for alcohol dependence: a preliminary open-label study. Alcoholism, Clinical and Experimental Research. 28: 1517-23. PMID 15597084 DOI: 10.1097/01.Alc.0000141640.48924.14  0.749
2004 Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 24: 421-8. PMID 15232334 DOI: 10.1097/01.Jcp.0000130555.63254.73  0.523
2003 Kampov-Polevoy AB, Garbutt JC, Khalitov E. Family history of alcoholism and response to sweets. Alcoholism, Clinical and Experimental Research. 27: 1743-9. PMID 14634489 DOI: 10.1097/01.Alc.0000093739.05809.Dd  0.558
2002 Golden RN, Heine AD, Ekstrom RD, Bebchuk JM, Leatherman ME, Garbutt JC. A longitudinal study of serotonergic function in depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 653-9. PMID 11927190 DOI: 10.1016/S0893-133X(01)00406-7  0.313
1999 West SL, Garbutt JC, Carey TS, Lux LJ, Jackman AM, Tolleson-Rinehart S, Lohr KN, Crews FT. Pharmacotherapy for alcohol dependence. Evidence Report/Technology Assessment (Summary). 1-5. PMID 11487800  0.518
1999 Kampov-Polevoy AB, Garbutt JC, Janowsky DS. Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol and Alcoholism (Oxford, Oxfordshire). 34: 386-95. PMID 10414615 DOI: 10.1093/Alcalc/34.3.386  0.578
1999 Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence: a review of the evidence. Jama. 281: 1318-25. PMID 10208148 DOI: 10.1001/Jama.281.14.1318  0.567
1998 Kampov-Polevoy AB, Garbutt JC, Davis CE, Janowsky DS. Preference for higher sugar concentrations and Tridimensional Personality Questionnaire scores in alcoholic and nonalcoholic men. Alcoholism, Clinical and Experimental Research. 22: 610-4. PMID 9622439 DOI: 10.1111/J.1530-0277.1998.Tb04300.X  0.574
1997 Mason GA, Rezvani AH, Overstreet DH, Hamedi M, Walker CH, Yang Y, Garbutt JC. Involvement of dopamine D2 receptors in the suppressive effect of the thyrotropin-releasing hormone analog TA-0910 on alcohol intake in alcohol-preferring rats. Alcoholism, Clinical and Experimental Research. 21: 1623-9. PMID 9438522 DOI: 10.1111/J.1530-0277.1997.Tb04499.X  0.531
1997 Hirsch AR, Kampov-Polevoy A, Garbutt JC, Janowsky D. High sucrose preference in alcoholic men [11] (multiple letters) American Journal of Psychiatry. 154: 1631-1632. PMID 9356589  0.459
1997 Rezvani AH, Garbutt JC, Overstreet DH, Li L, Walker CH, Yang Y, Mason GA. Thyrotropin releasing hormone analog TA-0910 suppresses alcohol intake in alcohol drinking African green monkeys. Alcoholism, Clinical and Experimental Research. 21: 261-6. PMID 9113262 DOI: 10.1111/J.1530-0277.1997.Tb03759.X  0.575
1997 Kampov-Polevoy A, Garbutt JC, Janowsky D. Evidence of preference for a high-concentration sucrose solution in alcoholic men. The American Journal of Psychiatry. 154: 269-70. PMID 9016281 DOI: 10.1176/Ajp.154.2.269  0.474
1997 Rezvani AH, Garbutt JC, Overstreet DH, Li L, Walker CH, Yang Y, Mason GA. Thyrotropin Releasing Hormone Analog TA-0910 Suppresses Alcohol Intake in Alcohol Drinking African Green Monkeys Alcoholism: Clinical and Experimental Research. 21: 261-266. DOI: 10.1111/J.1530-0277.1997.TB03759.X  0.506
1996 Mason GA, Rezvani AH, Overstreet DH, Garbutt JC. Thyrotropin-releasing hormone analog TA-0910 reduces voluntary alcohol intake of P rats subchronically in a limited scheduled access paradigm. Alcoholism, Clinical and Experimental Research. 20: 1000-3. PMID 8892518 DOI: 10.1111/J.1530-0277.1996.Tb01937.X  0.559
1996 Garbutt JC, Mayo JP, Little KY, Gillette GM, Mason GA, Dew B, Prange AJ. Dose-response studies with thyrotropin-releasing hormone: evidence for differential pituitary responses in men with major depression, alcoholism, or no psychopathology. Alcoholism, Clinical and Experimental Research. 20: 717-22. PMID 8800390 DOI: 10.1111/J.1530-0277.1996.Tb01677.X  0.54
1996 Janowsky D, Kampov A, Garbutt J. Sweet liking/novelty seeking interactions predict a diagnosis of alcoholism Biological Psychiatry. 39: 628. DOI: 10.1016/0006-3223(96)84378-2  0.404
1995 Garbutt JC, Miller LP, Mundle L, Senger M, Mason GA. Thyrotropin and prolactin responses to thyrotropin-releasing hormone in young men at high or low risk for alcoholism. Alcoholism, Clinical and Experimental Research. 19: 1133-40. PMID 8561281 DOI: 10.1111/J.1530-0277.1995.Tb01591.X  0.579
1995 Garbutt JC, Miller LP, Kramer G, Davis LL, Mason GA, Prange AJ, Petty F. Increased serum gamma-aminobutyric acid (GABA) levels in young men at high-risk for alcoholism. Biological Psychiatry. 38: 704-6. PMID 8555386 DOI: 10.1016/0006-3223(95)00286-3  0.407
1995 Petty F, Garbutt JC, Miller LP, Kramer GL, Davis LL, Mason GA, Prange AJ. Elevated levels of GABA in young men at high risk for alcoholism Biological Psychiatry. 37: 650. DOI: 10.1016/0006-3223(95)94618-7  0.447
1995 Garbutt J, Ridgway B, Silva S, Rezvani A, Mason G. Effects of high-dose intravenous TRH on craving and mood state in recently detoxified alcoholic men Biological Psychiatry. 37: 620. DOI: 10.1016/0006-3223(95)94514-W  0.523
1994 Garbutt JC, Miller LP, Karnitschnig JS, Mason GA. Thyrotropin response to thyrotropin-releasing hormone in young men at high or low risk for alcoholism. Annals of the New York Academy of Sciences. 708: 129-33. PMID 8154673 DOI: 10.1111/J.1749-6632.1994.Tb24705.X  0.49
1994 Garbutt JC, Mayo JP, Little KY, Gillette GM, Mason GA, Dew B, Prange AJ. Dose-response studies with protirelin. Archives of General Psychiatry. 51: 875-83. PMID 7944876 DOI: 10.1001/Archpsyc.1994.03950110035006  0.322
1994 Mason GA, Rezvani AH, Grady DR, Garbutt JC. The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance. Alcoholism, Clinical and Experimental Research. 18: 1196-201. PMID 7847606 DOI: 10.1111/J.1530-0277.1994.Tb00104.X  0.567
1994 Garbutt JC, Miller LP, Mundle L, Senger M, Karnitschnig J, Mason GA. Pituitary response to TRH in young men at risk for alcoholism Biological Psychiatry. 35: 692. DOI: 10.1016/0006-3223(94)90934-2  0.526
1992 Rezvani AH, Garbutt JC, Shimoda K, Garges PL, Janowsky DS, Mason GA. Attenuation of alcohol preference in alcohol-preferring rats by a novel TRH analogue, TA-0910. Alcoholism, Clinical and Experimental Research. 16: 326-30. PMID 1590553 DOI: 10.1111/J.1530-0277.1992.Tb01385.X  0.483
1992 Corrigan MH, Gillette GM, Quade D, Garbutt JC. Panic, suicide, and agitation: independent correlates of the TSH response to TRH in depression. Biological Psychiatry. 31: 984-92. PMID 1511081 DOI: 10.1016/0006-3223(92)90092-E  0.309
1992 Garbutt JC, McDavid J, Mason GA, Quade D, Loosen PT. Evidence for normal feedback inhibition of triiodothyronine on the thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in abstinent male alcoholics. Alcoholism, Clinical and Experimental Research. 16: 881-3. PMID 1443425 DOI: 10.1111/J.1530-0277.1992.Tb01886.X  0.485
1992 Golden RN, Ekstrom D, Brown TM, Ruegg R, Evans DL, Haggerty JJ, Garbutt JC, Pedersen CA, Mason GA, Browne J. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects. The American Journal of Psychiatry. 149: 1168-75. PMID 1323933 DOI: 10.1176/Ajp.149.9.1168  0.313
1991 Garbutt JC, Hicks RE, Clayton CJ, Andrews RT, Mason GA. Behavioral and endocrine interactions between thyrotropin-releasing hormone and ethanol in normal human subjects. Alcoholism, Clinical and Experimental Research. 15: 1045-9. PMID 1789379 DOI: 10.1111/J.1530-0277.1991.Tb05209.X  0.3
1991 Garbutt JC, Mayo JP, Gillette GM, Little KY, Hicks RE, Mason GA, Prange AJ. Dose-response studies with thyrotropin-releasing hormone (TRH) in abstinent male alcoholics: evidence for selective thyrotroph dysfunction? Journal of Studies On Alcohol. 52: 275-80. PMID 1646352  0.465
1987 Loosen PT, Garbutt JC, Prange AJ. Evaluation of the diagnostic utility of the TRH-induced TSH response in psychiatric disorders. Pharmacopsychiatry. 20: 90-5. PMID 3110800 DOI: 10.1055/s-2007-1017081  0.409
1986 Loosen PT, Garbutt JC, Tipermas A. The TRH test during dopamine receptor blockade in depressed patients. Psychoneuroendocrinology. 11: 327-36. PMID 3097692 DOI: 10.1016/0306-4530(86)90018-1  0.302
1986 Hsiao JK, Garbutt JC, Loosen PT, Mason GA, Prange AJ. Is there paradoxical growth hormone response to thyrotropin-releasing hormone in depression? Biological Psychiatry. 21: 595-600. PMID 3085739 DOI: 10.1016/0006-3223(86)90120-4  0.315
1984 Garbutt JC, Loosen PT. A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics. Psychoneuroendocrinology. 9: 311-4. PMID 6436858 DOI: 10.1016/0306-4530(84)90011-8  0.333
Show low-probability matches.